Indaptus Therapeutics Ownership 2024 | Who Owns Indaptus Therapeutics Now?

Overview RevenueFinancials Chart

Institutional Ownership

3.29%

Insider Ownership

26.67%

Retail Ownership

70.03%

Institutional Holders

6.00

Indaptus Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	3.04%	-	256,265	-	-	543,282	Jun 30, 2024
INVESTMENT HOUSE LLC	1.21%	0.01%	102,437	-	-	217,166	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.70%	-	59,309	4,542	8.29%	125,755	Jun 30, 2024
STRATEGY ASSET MANAGERS LLC	0.54%	0.02%	45,336	-	-	86,592	Jun 30, 2024
PINE VALLEY INVESTMENTS LTD LIABILITY CO	0.52%	0.01%	44,085	-60	-0.14%	93,461	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.32%	0.00%	26,600	500	1.92%	56,392	Jun 30, 2024
VIVALDI CAPITAL MANAGEMENT LP	0.28%	0.01%	24,000	-	-	50,880	Jun 30, 2024
STATE STREET CORP	0.15%	-	13,073	-	-	27,715,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	4,102	36	0.89%	8,696	Jun 30, 2024
MORGAN STANLEY	0.01%	-	884	-	-	1,874	Jun 30, 2024
UBS GROUP AG	0.01%	-	692	-1,244	-64.26%	1,467	Jun 30, 2024
BANGOR SAVINGS BANK	0.00%	0.00%	400	-	-	848	Jun 30, 2024
BEAIRD HARRIS WEALTH MANAGEMENT, LLC	0.00%	0.00%	300	300	100.00%	636	Jun 30, 2024
FMR LLC	0.00%	-	79	79	100.00%	167	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	64	-41	-39.05%	136	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	42	42	100.00%	89	Jun 30, 2024
JPMORGAN CHASE & CO	0.00%	-	15	1	7.14%	32	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.00%	-	7	-	-	15,000	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	1	-	-	2	Jun 30, 2024
VIRTU FINANCIAL LLC	-	-	-	-14,232	-100.00%	-	Jun 30, 2024

Indaptus Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 3.04% of the company's total share outstanding, currently valued at $543.28K. The top 10 institutional shareholders own together 6.82% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
STRATEGY ASSET MANAGERS LLC	0.54%	0.02%	45,336	-	-	86,592	Jun 30, 2024
VIVALDI CAPITAL MANAGEMENT LP	0.28%	0.01%	24,000	-	-	50,880	Jun 30, 2024
INVESTMENT HOUSE LLC	1.21%	0.01%	102,437	-	-	217,166	Jun 30, 2024
PINE VALLEY INVESTMENTS LTD LIABILITY CO	0.52%	0.01%	44,085	-60	-0.14%	93,461	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	4,102	36	0.89%	8,696	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.32%	0.00%	26,600	500	1.92%	56,392	Jun 30, 2024
BANGOR SAVINGS BANK	0.00%	0.00%	400	-	-	848	Jun 30, 2024
BEAIRD HARRIS WEALTH MANAGEMENT, LLC	0.00%	0.00%	300	300	100.00%	636	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.70%	-	59,309	4,542	8.29%	125,755	Jun 30, 2024
VANGUARD GROUP INC	3.04%	-	256,265	-	-	543,282	Jun 30, 2024
STATE STREET CORP	0.15%	-	13,073	-	-	27,715,000	Jun 30, 2024
UBS GROUP AG	0.01%	-	692	-1,244	-64.26%	1,467	Jun 30, 2024
MORGAN STANLEY	0.01%	-	884	-	-	1,874	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.00%	-	7	-	-	15,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	64	-41	-39.05%	136	Jun 30, 2024
FMR LLC	0.00%	-	79	79	100.00%	167	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	42	42	100.00%	89	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	1	-	-	2	Jun 30, 2024
JPMORGAN CHASE & CO	0.00%	-	15	1	7.14%	32	Jun 30, 2024
VIRTU FINANCIAL LLC	-	-	-	-14,232	-100.00%	-	Jun 30, 2024

The largest Indaptus Therapeutics shareholder by % of total assets is STRATEGY ASSET MANAGERS LLC. The company owns 45.34K shares of Indaptus Therapeutics (INDP), representing 0.02% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GEODE CAPITAL MANAGEMENT, LLC	0.70%	-	59,309	4,542	8.29%	125,755	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.32%	0.00%	26,600	500	1.92%	56,392	Jun 30, 2024
BEAIRD HARRIS WEALTH MANAGEMENT, LLC	0.00%	0.00%	300	300	100.00%	636	Jun 30, 2024
FMR LLC	0.00%	-	79	79	100.00%	167	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	42	42	100.00%	89	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	4,102	36	0.89%	8,696	Jun 30, 2024
JPMORGAN CHASE & CO	0.00%	-	15	1	7.14%	32	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	1	-	-	2	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.00%	-	7	-	-	15,000	Jun 30, 2024
MORGAN STANLEY	0.01%	-	884	-	-	1,874	Jun 30, 2024
STATE STREET CORP	0.15%	-	13,073	-	-	27,715,000	Jun 30, 2024
VANGUARD GROUP INC	3.04%	-	256,265	-	-	543,282	Jun 30, 2024
BANGOR SAVINGS BANK	0.00%	0.00%	400	-	-	848	Jun 30, 2024
INVESTMENT HOUSE LLC	1.21%	0.01%	102,437	-	-	217,166	Jun 30, 2024
VIVALDI CAPITAL MANAGEMENT LP	0.28%	0.01%	24,000	-	-	50,880	Jun 30, 2024
STRATEGY ASSET MANAGERS LLC	0.54%	0.02%	45,336	-	-	86,592	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	64	-41	-39.05%	136	Jun 30, 2024
PINE VALLEY INVESTMENTS LTD LIABILITY CO	0.52%	0.01%	44,085	-60	-0.14%	93,461	Jun 30, 2024
UBS GROUP AG	0.01%	-	692	-1,244	-64.26%	1,467	Jun 30, 2024
VIRTU FINANCIAL LLC	-	-	-	-14,232	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Indaptus Therapeutics's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 4.54K stocks of INDP, valued at $125.75K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	-	-	-	-14,232	-100.00%	-	Jun 30, 2024
UBS GROUP AG	0.01%	-	692	-1,244	-64.26%	1,467	Jun 30, 2024
PINE VALLEY INVESTMENTS LTD LIABILITY CO	0.52%	0.01%	44,085	-60	-0.14%	93,461	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	64	-41	-39.05%	136	Jun 30, 2024
STRATEGY ASSET MANAGERS LLC	0.54%	0.02%	45,336	-	-	86,592	Jun 30, 2024
VIVALDI CAPITAL MANAGEMENT LP	0.28%	0.01%	24,000	-	-	50,880	Jun 30, 2024
INVESTMENT HOUSE LLC	1.21%	0.01%	102,437	-	-	217,166	Jun 30, 2024
BANGOR SAVINGS BANK	0.00%	0.00%	400	-	-	848	Jun 30, 2024
VANGUARD GROUP INC	3.04%	-	256,265	-	-	543,282	Jun 30, 2024
STATE STREET CORP	0.15%	-	13,073	-	-	27,715,000	Jun 30, 2024
MORGAN STANLEY	0.01%	-	884	-	-	1,874	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.00%	-	7	-	-	15,000	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	1	-	-	2	Jun 30, 2024
JPMORGAN CHASE & CO	0.00%	-	15	1	7.14%	32	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.05%	0.00%	4,102	36	0.89%	8,696	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	42	42	100.00%	89	Jun 30, 2024
FMR LLC	0.00%	-	79	79	100.00%	167	Jun 30, 2024
BEAIRD HARRIS WEALTH MANAGEMENT, LLC	0.00%	0.00%	300	300	100.00%	636	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.32%	0.00%	26,600	500	1.92%	56,392	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.70%	-	59,309	4,542	8.29%	125,755	Jun 30, 2024

As of Jun 30 2024, Indaptus Therapeutics's biggest institutional seller is VIRTU FINANCIAL LLC. The company sold -14.23K shares of INDP, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BEAIRD HARRIS WEALTH MANAGEMENT, LLC	0.00%	0.00%	300	300	100.00%	636	Jun 30, 2024
FMR LLC	0.00%	-	79	79	100.00%	167	Jun 30, 2024

Indaptus Therapeutics's largest new institutional shareholder by number of shares is BEAIRD HARRIS WEALTH MANAGEMENT, LLC, purchased 300.00 shares, valued at $636.00, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	-	-	-	-14,232	-100.00%	-	Jun 30, 2024

Indaptus Therapeutics's largest sold out institutional shareholder by shares sold is VIRTU FINANCIAL LLC, sold -14.23K shares, valued at -, as of undefined.

Indaptus Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY COMMONWEALTH TRUST	0.02%	61,459	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	256,265	-27,068	-9.55%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	51,433	-207	-0.40%	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	765	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	527	-	-	Mar 31, 2024

Indaptus Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 61.46K shares, compromising 0.02% of its total assets.

Indaptus Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	6	-64.71%
31 Mar, 24	17	-5.56%
31 Dec, 23	18	12.50%
30 Sep, 23	16	6.67%
30 Jun, 23	15	-
31 Mar, 23	15	-6.25%
31 Dec, 22	16	23.08%
30 Sep, 22	13	8.33%
30 Jun, 22	12	9.09%
31 Mar, 22	11	-
31 Dec, 21	11	22.22%
30 Sep, 21	9	-

As of 30 Jun 24, 6 institutions are holding Indaptus Therapeutics's shares, representing a decrease of -64.71% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	278,167	-52.67%
31 Mar, 24	587,768	-2.40%
31 Dec, 23	602,239	5.56%
30 Sep, 23	570,529	-2.26%
30 Jun, 23	583,740	0.76%
31 Mar, 23	579,339	0.51%
31 Dec, 22	576,419	1.68%
30 Sep, 22	566,898	13.18%
30 Jun, 22	500,887	-70.75%
31 Mar, 22	1,712,376	-6.75%
31 Dec, 21	1,836,293	239.12%
30 Sep, 21	541,486	-

Indaptus Therapeutics (INDP) has 278.17K shares outstanding as of 30 Jun 24, down -52.67% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	3.29%	6.73%
31 Mar, 24	7.00%	13.61%
31 Dec, 23	7.17%	15.54%
30 Sep, 23	6.79%	14.07%
30 Jun, 23	6.95%	14.61%
31 Mar, 23	6.90%	14.17%
31 Dec, 22	6.98%	14.81%
30 Sep, 22	6.86%	18.66%
30 Jun, 22	6.07%	1.41%
31 Mar, 22	20.73%	4.19%
31 Dec, 21	22.23%	13.25%
30 Sep, 21	12.95%	-

As of 30 Jun 24, Indaptus Therapeutics is held by 3.29% institutional shareholders, representing a 6.73% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	2	-33.33%
31 Mar, 24	3	-62.50%
31 Dec, 23	8	14.29%
30 Sep, 23	7	75.00%
30 Jun, 23	4	-33.33%
31 Mar, 23	6	-
31 Dec, 22	6	-
30 Sep, 22	6	50.00%
30 Jun, 22	4	-20.00%
31 Mar, 22	5	-44.44%
31 Dec, 21	9	-
30 Sep, 21	9	-

2 institutional shareholders have increased their position in INDP stock as of 30 Jun 24 compared to 3 in the previous quarter (a -33.33% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	1	-80.00%
31 Mar, 24	5	150.00%
31 Dec, 23	2	-50.00%
30 Sep, 23	4	100.00%
30 Jun, 23	2	100.00%
31 Mar, 23	1	-66.67%
31 Dec, 22	3	50.00%
30 Sep, 22	2	-33.33%
30 Jun, 22	3	50.00%
31 Mar, 22	2	100.00%
31 Dec, 21	1	-
30 Sep, 21	-	-

1 institutional shareholders have reduced their position in INDP stock as of 30 Jun 24 compared to 5 in the previous quarter (a -80.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	6	-64.71%	278,167	-52.67%	3.29%	6.73%	2	-33.33%	1	-80.00%
31 Mar, 24	17	-5.56%	587,768	-2.40%	7.00%	13.61%	3	-62.50%	5	150.00%
31 Dec, 23	18	12.50%	602,239	5.56%	7.17%	15.54%	8	14.29%	2	-50.00%
30 Sep, 23	16	6.67%	570,529	-2.26%	6.79%	14.07%	7	75.00%	4	100.00%
30 Jun, 23	15	-	583,740	0.76%	6.95%	14.61%	4	-33.33%	2	100.00%
31 Mar, 23	15	-6.25%	579,339	0.51%	6.90%	14.17%	6	-	1	-66.67%
31 Dec, 22	16	23.08%	576,419	1.68%	6.98%	14.81%	6	-	3	50.00%
30 Sep, 22	13	8.33%	566,898	13.18%	6.86%	18.66%	6	50.00%	2	-33.33%
30 Jun, 22	12	9.09%	500,887	-70.75%	6.07%	1.41%	4	-20.00%	3	50.00%
31 Mar, 22	11	-	1,712,376	-6.75%	20.73%	4.19%	5	-44.44%	2	100.00%
31 Dec, 21	11	22.22%	1,836,293	239.12%	22.23%	13.25%	9	-	1	-
30 Sep, 21	9	-	541,486	-	12.95%	-	9	-	-	-

Indaptus Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	23,934	$2.34	$56.01K	1,190,400
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	35,064	$2.12	$74.34K	1,166,466
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	44,354	$1.94	$86.05K	1,131,402

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	23,934	$2.34	$56.01K	1,190,400
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	35,064	$2.12	$74.34K	1,166,466
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	44,354	$1.94	$86.05K	1,131,402

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 08, 2024	Meckler Jeffrey A	director, officer	CEO and Director	A-Award	Buy	84,932	$1.82	$155.00K	160,306
Aug 08, 2024	Meckler Jeffrey A	director, officer	CEO and Director	A-Award	Buy	84,932	$1.70	$144.38K	84,932
Jun 07, 2024	Karah Hila	director	-	A-Award	Buy	12,500	$2.63	$32.88K	12,500
Jun 07, 2024	Gilbert Mark John	director	-	A-Award	Buy	12,500	$2.63	$32.88K	12,500
Jun 07, 2024	Pomerantz Roger	director	-	A-Award	Buy	30,000	$2.63	$78.90K	30,000
Jun 07, 2024	MADDALUNA ANTHONY J	director	-	A-Award	Buy	12,500	$2.63	$32.88K	12,500
Jun 07, 2024	Martell Robert	director	-	A-Award	Buy	12,500	$2.63	$32.88K	12,500
Jun 07, 2024	Hayes William B	director	-	A-Award	Buy	12,500	$2.63	$32.88K	12,500
Jan 23, 2024	Linscott Walt Addison	officer	Chief Operating Officer	A-Award	Buy	75,000	$1.74	$130.50K	75,000
Jan 23, 2024	Waltzman Roger J.	officer	Chief Medical Officer	A-Award	Buy	75,000	$1.74	$130.50K	75,000
Jan 23, 2024	Sassi Nir	officer	Chief Financial Officer	A-Award	Buy	40,000	$1.74	$69.60K	40,000
Jan 23, 2024	Meckler Jeffrey A	director, officer	CEO and Director	A-Award	Buy	100,000	$1.74	$174.00K	100,000
Jan 23, 2024	Newman Michael James	director, 10 percent owner, officer	CSO and Director	A-Award	Buy	43,250	$1.74	$75.25K	43,250
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	23,934	$2.34	$56.01K	1,190,400
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	35,064	$2.12	$74.34K	1,166,466
Aug 16, 2023	Anderson Glen R.	10 percent owner	-	P-Purchase	Buy	44,354	$1.94	$86.05K	1,131,402
Aug 07, 2023	Waltzman Roger J.	officer	Chief Medical Officer	A-Award	Buy	90,000	$1.85	$166.50K	90,000
Aug 07, 2023	Waltzman Roger J.	officer	-		Buy	-	-	-	-
May 30, 2023	Karah Hila	director	-	A-Award	Buy	12,500	$1.82	$22.75K	12,500
May 30, 2023	Hayes William B	director	-	A-Award	Buy	12,500	$1.82	$22.75K	12,500

The last insider buy of INDP was made by Anderson Glen R. on Aug 16 2023, buying 23,934 shares at $2.34 per share (worth $56.01K).

Indaptus Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	2	-	-
Q2 2024	6	-	-
Q1 2024	5	-	-
Q3 2023	4	-	-
Q2 2023	5	-	-
Q1 2023	5	-	-
Q4 2022	4	-	-
Q3 2022	9	-	-
Q2 2022	1	1	100.00%
Q1 2022	7	2	350.00%
Q4 2021	2	-	-
Q3 2021	11	34	32.35%

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Indaptus Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	-	-	-
Q1 2024	-	-	-
Q3 2023	3	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	4	-	-
Q3 2022	3	-	-
Q2 2022	1	-	-
Q1 2022	2	2	100.00%
Q4 2021	1	-	-
Q3 2021	1	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Indaptus Therapeutics's stocks.

Indaptus Therapeutics Peer Ownership

Ticker	Company
NTRB	Nutriband Inc.
MTCR	Metacrine, Inc.
BWV	Onconetix, Inc.
ABVC	ABVC BioPharma, Inc.
KPRX	Kiora Pharmaceuticals, Inc.
KTTA	Pasithea Therapeutics Corp.
LGVN	Longeveron Inc.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
VRAX	Virax Biolabs Group Limited
ASMB	Assembly Biosciences, Inc.
RNXT	RenovoRx, Inc.
RZLT	Rezolute, Inc.
TPST	Tempest Therapeutics, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
FBRX	Forte Biosciences, Inc.

INDP Ownership FAQ

Who Owns Indaptus Therapeutics?

Indaptus Therapeutics is owned by institutional shareholders (3.29%), insiders (26.67%), and public (70.03%). The largest institutional shareholder of Indaptus Therapeutics is VANGUARD GROUP INC (3.04% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.02% of total shares).

Who are the major institutional shareholders of Indaptus Therapeutics?

Indaptus Therapeutics's major institutional shareholders are VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, STRATEGY ASSET MANAGERS LLC, and PINE VALLEY INVESTMENTS LTD LIABILITY CO. The top five shareholders own together 6.01% of the company's share outstanding.

How many Indaptus Therapeutics shareholders are there?

As of Jun 2024, there are 6 institutional shareholders of Indaptus Therapeutics.

What percentage of Indaptus Therapeutics is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 256.26K shares of Indaptus Therapeutics, representing 3.04% of the company's total shares outstanding, valued at $543.28K (as of Jun 2024).

What percentage of Indaptus Therapeutics is owned by INVESTMENT HOUSE LLC?

As of Jun 2024, INVESTMENT HOUSE LLC holds 102.44K shares of Indaptus Therapeutics (INDP), compromising 1.21% of the company, valued at $217.17K.

What percentage of Indaptus Therapeutics is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Indaptus Therapeutics. The company owns 59.31K of the company's shares outstanding (worth $125.76K).